144 related articles for article (PubMed ID: 8590775)
1. Biology of flt3 ligand and receptor.
Lyman SD
Int J Hematol; 1995 Aug; 62(2):63-73. PubMed ID: 8590775
[TBL] [Abstract][Full Text] [Related]
2. The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor.
Lyman SD; Brasel K; Rousseau AM; Williams DE
Stem Cells; 1994; 12 Suppl 1():99-107; discussion 108-10. PubMed ID: 7535149
[TBL] [Abstract][Full Text] [Related]
3. Biology and potential clinical applications of flt3 ligand.
Lyman SD; Williams DE
Curr Opin Hematol; 1995 May; 2(3):177-81. PubMed ID: 9371992
[TBL] [Abstract][Full Text] [Related]
4. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
5. Fms-like tyrosine kinase 3 catalytic domain can transduce a proliferative signal in FDC-P1 cells that is qualitatively similar to the signal delivered by c-Fms.
Rossner MT; McArthur GA; Allen JD; Metcalf D
Cell Growth Differ; 1994 May; 5(5):549-55. PubMed ID: 8049161
[TBL] [Abstract][Full Text] [Related]
6. Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells.
Sitnicka E; Buza-Vidas N; Larsson S; Nygren JM; Liuba K; Jacobsen SE
Blood; 2003 Aug; 102(3):881-6. PubMed ID: 12676789
[TBL] [Abstract][Full Text] [Related]
7. Flt3/Flk-2 and c-Kit are not essential for the proliferation of B lymphoid progenitor cells in the bone marrow of the adult mouse.
Ogawa M; Sugawara S; Kunisada T; Sudo T; Hayashi S; Nishikawa S; Kodama H; Nishikawa S
Exp Hematol; 1998 Jun; 26(6):478-88. PubMed ID: 9620281
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells.
Lyman SD; James L; Vanden Bos T; de Vries P; Brasel K; Gliniak B; Hollingsworth LT; Picha KS; McKenna HJ; Splett RR
Cell; 1993 Dec; 75(6):1157-67. PubMed ID: 7505204
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the mitogenic pathway of the FLT3 receptor and characterization in its C terminal region of a specific binding site for the PI3' kinase.
Casteran N; Rottapel R; Beslu N; Lecocq E; Birnbaum D; Dubreuil P
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):443-56. PubMed ID: 7920189
[TBL] [Abstract][Full Text] [Related]
10. Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts.
Stacchini A; Fubini L; Severino A; Sanavio F; Aglietta M; Piacibello W
Leukemia; 1996 Oct; 10(10):1584-91. PubMed ID: 8847893
[TBL] [Abstract][Full Text] [Related]
11. Stem cell factor, but not flt3 ligand, induces differentiation and activation of human mast cells.
Hjertson M; Sundström C; Lyman SD; Nilsson K; Nilsson G
Exp Hematol; 1996 May; 24(6):748-54. PubMed ID: 8635531
[TBL] [Abstract][Full Text] [Related]
12. [Receptor tyrosine kinases (c-kit, c-fmns, Flt-3, Tie2, etc.)].
Yoshimura A; Sanada M; Mashima R
Nihon Rinsho; 2005 Apr; 63 Suppl 4():207-14. PubMed ID: 15861658
[No Abstract] [Full Text] [Related]
13. Bis(1H-2-indolyl)-1-methanones as inhibitors of the hematopoietic tyrosine kinase Flt3.
Teller S; Krämer D; Böhmer SA; Tse KF; Small D; Mahboobi S; Wallrapp C; Beckers T; Kratz-Albers K; Schwäble J; Serve H; Böhmer FD
Leukemia; 2002 Aug; 16(8):1528-34. PubMed ID: 12145694
[TBL] [Abstract][Full Text] [Related]
14. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs.
Hannum C; Culpepper J; Campbell D; McClanahan T; Zurawski S; Bazan JF; Kastelein R; Hudak S; Wagner J; Mattson J
Nature; 1994 Apr; 368(6472):643-8. PubMed ID: 8145851
[TBL] [Abstract][Full Text] [Related]
15. Biologic effects and potential clinical applications of Flt3 ligand.
Lyman SD
Curr Opin Hematol; 1998 May; 5(3):192-6. PubMed ID: 9664159
[TBL] [Abstract][Full Text] [Related]
16. FLT3: receptor and ligand.
Drexler HG; Quentmeier H
Growth Factors; 2004 Jun; 22(2):71-3. PubMed ID: 15253381
[TBL] [Abstract][Full Text] [Related]
17. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities.
Lyman SD; Jacobsen SE
Blood; 1998 Feb; 91(4):1101-34. PubMed ID: 9454740
[No Abstract] [Full Text] [Related]
18. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells.
Lyman SD; James L; Johnson L; Brasel K; de Vries P; Escobar SS; Downey H; Splett RR; Beckmann MP; McKenna HJ
Blood; 1994 May; 83(10):2795-801. PubMed ID: 8180375
[TBL] [Abstract][Full Text] [Related]
19. Regulatory roles of the ligand for Flk2/Flt3 tyrosine kinase receptor on human hematopoiesis.
Namikawa R; Muench MO; Roncarolo MG
Stem Cells; 1996 Jul; 14(4):388-95. PubMed ID: 8843540
[TBL] [Abstract][Full Text] [Related]
20. The expression of FMS, KIT and FLT3 in hematopoietic malignancies.
Birg F; Rosnet O; Carbuccia N; Birnbaum D
Leuk Lymphoma; 1994 Apr; 13(3-4):223-7. PubMed ID: 7519507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
